Purpose of Review To describe current indications, implants, economic benefits, comparison to TKA, and functional and patient-reported outcomes of patellofemoral arthroplasty. Recent Findings Modern onlay implants and improved patient selection have allowed for recent improvements in short-and long-term outcomes after patellofemoral joint replacement surgery. Summary Patellofemoral arthroplasty has become an increasingly utilized technique for the successful treatment of isolated patellofemoral arthritis. Advances in patient selection, implant design, and surgical technique have resulted in improved performance and longevity of these implants. Although short-and mid-term data for modern patellofemoral arthroplasties appear promising, further long-term clinical studies are needed to evaluate how new designs and technologies will affect patient outcomes and long-term implant performance.
Introduction
Osteoarthritis (OA) of the knee is relatively common and epidemiologic studies have demonstrated that 10% of these patients over 40 years old have OA confined to the patellofemoral joint [1] . Isolated degeneration of the patellofemoral articulation has also been reported in 24% of women and 11% of men greater than 55 years who present with symptomatic knee arthritis [2] . These patients are typically younger and female, whose condition results from abnormal loading across the patellofemoral joint. Many patients attempt conservative treatments such as physical therapy, bracing, injections, weight loss, and activity modification. Failure to experience improvements through these measures often results in the decision to seek surgical care [3] . Joint-preserving procedures include chondroplasty, microfracture, lateral release, autologous cartilage implantation, and tibial tubercle transfer (TTT), although these do not produce consistent results.
The surgical "gold standard" for knee OA has traditionally been total knee arthroplasty (TKA), which literature has demonstrated to provide good long-term outcomes. However, TKA surgery results in the loss of normal knee kinematics and markedly limits the types of activities and the activity level that patients can return to after surgery. Another alternative for patients with isolated patellofemoral OA is patellofemoral arthroplasty (PFA). This bone-and ligament-conserving partial knee replacement more accurately reproduces the natural knee movements compared to TKA.
limitations, such as narrow anterior femoral flange width and suboptimal trochlear implant geometry, led to patellar tracking problems, instability, subluxation, and impingement. Failure rates were reported between 17.8-44%, 20-33%, 10-42%, and 16-78%, in the Depuy's Autocentric™, Depuy's LCS™, Smith & Nephew's Richards™, and Waldemar's Lubinus™, respectively [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] .
These high failure rates necessitated the development of second-generation onlay implants that use the same anterior femoral cut as TKA, thus replacing the cartilage and subchondral bone of the anterior compartment of the knee (Fig. 2) . These designs include a broad trochlear surface and valgus tracking angle to promote appropriate patellar tracking [3] . The surgeon could further optimize patellar tracking by controlling the amount of external rotation with which the anterior cut is made. Also, in cases of patellofemoral instability and arthritis, second-generation PFA could be combined with medial patellofemoral ligament (MPFL) reconstruction to address both diagnoses simultaneously. Finally, if significant patellar subluxation or tilt without instability is present, the more forgiving trochlear design of the second-generation onlay implants could allow that to be addressed through medialization of the tibial tuberosity with or without lateral retinaculum release and/or lateral facetectomy during the same procedure.
One of the most studied second-generation implants is the Avon patellofemoral replacement, which accounts for 40% of all PFAs according to the National Joint Registry of England and Wales (Stryker, Howmedica Osteonics, Allendale, NJ, USA). The features of this implant are a 3 mm medially offset patellar dome and a broad, symmetrical femoral trochlear flange that narrows distally, which overall facilitates patellar tracking, stability, and engagement during flexion with minimal constraint during extension [24] . Survivorship for the Avon implant at 5 years ranges from 96.1-100%, and the documented revision rate at 5 years of 7.76% is lower than the 9.51% revision rate for all PFAs [24] [25] [26] [27] [28] [29] [30] [31] [32] .
Another relatively new second-generation implant with a symmetrical trochlear component is the Femoro Patella Vialli (FPV) (Wright Medical Technology, Arlington, TN, USA), which is reported to have a 3-year survival rate between 85 and 97% [33] [34] [35] . Al-Hadity's FPV study demonstrated this implant to have comparable survivorship, 97% at 5 years, and improvements in Oxford Knee Score, which measures pain and function, compared to the Avon implant. A more recent study showed similarly encouraging results with no implant failures observed and only one revision to TKA due to postoperative rheumatoid arthritis diagnosis [36] .
Several other second-generation implant designs exist; however, there is a paucity of outcomes reported in the literature. This includes Depuy's second-generation Sigma patellofemoral implant (Warsaw, IN, USA), which has been redesigned to decrease the overhang impingement commonly associated with postoperative anterior knee pain. Overall, this implant has shown significantly improved survivorship, 92% at 2 years, compared to Depuy's first-generation implants, the Autocentric and LCS [37, 38] . The Natural Knee II Patello-femoral Joint System (Zimmer, Warsaw, IN, USA) has demonstrated a 90% survivorship at 5-year follow-up. In their initial cohort of 40 knees in 34 patients, the designers reported that two patients underwent revision for traumatic injuries, one patient was revised for retained cement that eroded the patellar component, and a fourth patient was converted to TKA for an unknown reason at an outside institution [39] .
Some companies have opted to create second-generation designs with an asymmetric trochlea, in which an elevated lateral flange resists the lateralizing forces exerted by the quadriceps [40] . These designs include the JourneyCompetitor, Vanguard, Hermes, Gender Solutions, and Leicester models.
In particular, the JourneyCompetitor (Smith & Nephew, Andover, MA, USA) was designed with a lateralized and deepened trochlear groove to improve patellar tracking throughout flexion and extension. This implant was shown to improve daily pain and clinical scores at 2 years postoperatively, and the greatest improvements were observed in patients being treated for concomitant patellofemoral instability [41] .
The Vanguard prosthesis (Biomet, Warsaw, IN, USA) was designed with a trochlea that extends to the intercondylar notch and allows the convex patellar button to remain in contact from full extension to 100 o of flexion, though there is the potential for ACL impingement. This prosthesis had a 94.3% survivorship at an average of 3.7 years; out of 53 patients evaluated, one revision was due to neuropathic pain and two revisions were due to perisprosthetic patellar fractures in patients after falling [42] .
Similarly, the Hermes prosthesis (Ceravor, Roissy-en-France, France) was designed to reduce the loads on the lateral facet by allowing more external rotation and translocation of the femoral trochlear component by incorporating 7 o of valgus into the trochlear groove. In a study of 85 implants at 10-year follow-up, three underwent conversion to TKA due to disease progression, and only four patients experienced slight lateral patellar subluxation and tilt. There were no failures for dislocation, fracture, wear, or maltracking [43] .
Given that over 75% of PFAs are performed in women, the Gender Solutions (Zimmer, Warsaw, IN, USA) was designed and tailored to better fit female patients with a naturally increased trochlear groove angle [44, 45] . This implant demonstrated a survival rate of 95.6% at 3 years, with all failures being conversions to TKA due to progression of osteoarthritis [46•] .
The implant with the best recorded survivorship in the literature is a custom patellofemoral implant design, the KineMatch Custom PFR™ (Camarillo, CA, USA) [47, 48] . Twenty-five knees in 22 patients have demonstrated a survivorship of 100% at an average of 11.3 years, with no additional required surgeries or component loosening. Though all knees experienced some degree of pain, there were no reports of weakness or instability. Though this custom prosthesis is more expensive, the purported benefits include a patientspecific anatomic fit and appropriate patellofemoral alignment and medial-lateral constraint at the time of surgery.
Overall, improvements have been made in the understanding of patellar stability and tracking, and outcomes have improved due to advances in surgical indications, new implant designs, component positioning, and soft tissue balancing [49, 50] . Survivorship of both first-and second-generation PFA implants, calculated using a Kaplan-Meier estimation, is 91.7, 83.3, 74.9, and 66.6% at 5, 10, 15, and 20 years, respectively [51] (Fig. 3) . Though the revision rates for second-generation PFA have improved dramatically, some patients are still not satisfied with their surgeries. Currently, there is scant literature on how the psychosocial aspects of undergoing PFA affect patient outcomes. One recent study determined that dissatisfied patients and those whose expectations were not met had significantly lower Mental Health scores (Short Form-36) after PFA, despite clinical and radiographic success of the PFA implant [52•] . These results imply that poor mental health may partially explain low patient satisfaction, though future studies are necessary to further explore the impact of mental health on knee arthroplasty outcomes.
Indications/Contraindications
In addition to improved implant design, careful patient selection has been recognized as a critical factor in determining the success of PFA [5, 20, 53, 54] . The ideal candidate for PFA has primary or post-traumatic isolated patellofemoral OA or has developed patellofemoral arthritis associated with recurrent patellar subluxation or dysplasia of the trochlea [14, 55] . Patients with significant pain or evidence of OA in the medial or lateral tibiofemoral compartments should be excluded from PF arthroplasty, as well as those with tibiofemoral malalignment and inflammatory joint disease.
There is currently conflicting information regarding the effect of BMI on outcomes after PFA. While some studies demonstrate that obesity did not affect outcomes, a recent retrospective report indicates that a BMI 30 ≥ kg/m 2 resulted in lower patient satisfaction and no significant improvements in functional outcomes, as measured by the Melbourne Knee score and the Knee Society function score [38] . The same study, as well as another by Dahm et al., showed that the absence of trochlear dysplasia put patients at a higher risk of conversion surgery to TKA due to greater progression of tibiofemoral joint disease than patients with trochlear dysplasia [56] .
Robotic PFA
As interest in robotic-assisted arthroplasty continues to increase, surgeons have applied these technologies to PFA [57•] . Although several studies looking at the clinical and radiographic outcomes of bicompartmental arthroplasty have been published, no studies on robotic PFA are available [58] [59] [60] . One study has reported that there were no complications related to the pin sites following robotic joint replacement, demonstrating the low morbidity associated with this arthroplasty technique [61] . Although there are numerous studies demonstrating that robotic-assisted arthroplasty improves component positioning and alignment [62] , it remains to be seen how new technologies will affect outcomes and survivorship of PFA.
PFA versus TKA
Complication, revision, and conversion rates after PFA surgery have led to controversy over the surgical treatment for isolated patellofemoral OA. The most recent research seeks to compare outcomes of PFA compared to the "gold standard," TKA.
An early retrospective comparison study of PFA versus TKA described benefits of improved function, return to higher activity, and less morbidity in the PFA patients using the AVON implant [63] . There were no revisions nor further surgery needed after PFA, compared to the TKA group, in which one patient required manipulation for stiffness and one patient developed deep vein thrombosis after surgery. While both groups experienced similar pain relief results and satisfaction, PFA patients had shorter hospital stays after surgery, less blood loss, and fewer complications.
A 2011 meta-analysis of 28 studies showed no significant differences in reoperation, revision, pain, or mechanical complications between second-generation PFA and TKA [64] . However, first-generation PFA did have higher complication and reoperation rates when compared to second-generation PFA [64] (Table 1) . Similarly, second-generation PFA revision and reoperation rates (0.4 and 2.7%) were found to be comparable to the revision and reoperation rates in primary TKA (0.5 and 2.0%) from early and mid-term follow-up studies [65•] . However, this study also demonstrated that survivorship was significantly lower in second-generation PFA than TKA.
A 2017 randomized clinical trial found that TKA patients lost almost 3 months of knee function in the first 2 years and had longer recoveries compared to PFA patients [66•] . PFA patients in the study also demonstrated a greater range of motion, better physical function scores, less pain, and significantly better results for all of the "symptoms" dimensions of the KOOS and OKS. 
TKA Conversion
PFA is sometimes viewed as a bridging surgery for younger patients until they require conversion to TKA [67] . However, this concept has been met with some skepticism as it was unclear whether the functional outcomes of conversion of PFA to TKA would be more consistent with primary or revision TKA.
A recent 2017 systematic review of 39 cohort studies and three registries assessed the causes of 938 PFA failures from 1996 to 2015. Overall, PFA failure was due to OA progression (38%), pain (16%), aseptic loosening (14%), and patellar maltracking (14%) [68•] . On closer inspection, early failures in more recent studies were mostly attributed to pain (31%), while late failures in older studies were a result of OA progression (46%) [26, 69] (Table 2) .
A 2006 study on the conversion of 12 PFA to TKA in ten patients demonstrated significantly improved Knee Society clinical and functional scores at a mean follow-up of 3.1 years. There was neither clinical nor radiographic evidence of patellofemoral maltracking, loosening, or wear. Despite short-term follow-up, the results of the TKA did not appear to be compromised after conversion of failed PFA [70] . In two other small studies, it was also suggested that conversion of PFA to TKA has postoperative patient outcomes and surgical characteristics comparable to primary TKA and superior to revision TKA [71•, 72] . Although there were higher complication rates and less satisfaction for PFA conversion to TKA than primary TKA, conversion surgeries used a standard TKA implant and rarely had to revise the patellar button, making them relatively straightforward [71•, 73] .
Economic Benefits
While the attractiveness of PFA has been driven by its more conservative nature in terms of bony resection and knee kinematics, particularly in younger patients, many have contended that it lacks long-term economic advantages when compared to TKA because of higher revision rates. Currently, there are no randomized clinical trials (RCT) that compare the quality of life outcome assessments, functional knee scores, and complication rates between the two arthroplasty techniques [32] . However, the cost-effectiveness of PFA versus TKA has been assessed using a Markov transition state model and revision rates derived from the National Joint Registry for England, Wales, Northern Ireland, and the Isle of Man [74•] . This study assessed lifetime costs, quality-adjusted life year (QALY) gains, and incremental cost-effectiveness ratio (ICER) from a healthcare payer perspective and determined that PFA was more expensive than TKA ($49,811 versus $46,632, respectively), but also more effective (14.3 QALYs versus 13.3 QALYs, respectively). When accounting for the functional advantages and implant survivorship of PFA, the model's results suggest that a 24.5% decrease in annual rates of PFA revision would make it both less expensive and more effective than PFA, patellofemoral arthroplasty; OA prog, progression of osteoarthritis; Asep. loos., Aseptic loosening; Maltrack., Maltracking of the patella; Malpos., Malpositioning of components TKA. Though PFA is considered cost-effective when it provides at least a 1.0% greater utility than TKA, further data is necessary to quantify health-related quality of life between the two arthroplasty techniques.
Conclusions
Patellofemoral arthroplasty is a bone-conserving arthroplasty technique used to successfully treat isolated patellofemoral arthritis. From its inception as a patellar resurfacing prosthesis in the 1950s, the procedure has greatly advanced through new implant designs, better patient selection, and improved surgical techniques. While the revision and reoperation rates of secondgeneration PFA implants are now approaching other partial knee replacements, the survivorship of second-generation PFA implants is still significantly lower than TKA. However, in general, PFA patients experience a shorter recovery, less blood loss, less pain, better physical function, and a greater range of motion than TKA patients. Progression of tibiofemoral arthritis represents up to one-third of PFA conversions and thus more stringent patient selection for isolated patellofemoral arthritis may optimize outcomes. Encouragingly, PFA conversion to TKA has similar postoperative patient outcomes and surgical characteristics to primary TKA, although conversion TKA does have higher complication rates. Recent improvements in PFA implant design and more meticulous patient selection have improved survivorship, making PFA an economically beneficial joint-preserving procedure in younger patients. Future studies assessing the longterm results of new designs and technologies of PFA as well as comparison studies to TKA are necessary to evaluate patient outcomes and implant performance.
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